miRNA Therapy Targeting Cancer Stem cells: a New Paradigm for Cancer Treatment and Prevention of Tumor Recurrence

References

• Jemal A Bray F Center MM Ferlay J Ward E Forman D . Global cancer statistics. CA. Cancer J. Clin.61 (2), 69–90 (2011).
   PubMed Web of Science ®Google Scholar
• Hanahan D Weinberg RA . Hallmarks of cancer: the next generation. Cell144 (5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Reya T Morrison SJ Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature414, 105–111 (2001).
   PubMed Web of Science ®Google Scholar
• Alison MR Islam S Wright NA . Stem cells in cancer: instigators and propagators?J. Cell Sci.123, 2357–2368 (2010).
   PubMed Web of Science ®Google Scholar
• Friedman GK Gillespie GY . Cancer stem cells and pediatric solid tumors. Cancer3, 298–318 (2011).
   Google Scholar
• Clarke MF Fuller M . Stem cells and cancer: two faces of eve. Cell124, 1111–1115 (2006).
   PubMed Web of Science ®Google Scholar
• Greaves M . Cancer stem cells: back to Darwin?Semin. Cancer Biol.20, 65–70 (2010).
   PubMed Web of Science ®Google Scholar
• Jordan CT Guzman ML Noble M . Cancer stem cells. N. Engl. J. Med.355, 1253–1261 (2006).
   PubMed Web of Science ®Google Scholar
• Cohnheim J . Congenitales, quergestreiftes Muskelsarkon der Nireren. Virchows Arch.65, 64–69 (1875).
   Google Scholar
• Wicha MS Liu S Dontu G . Cancer stem cells: an old idea–a paradigm shift. Cancer Res.66, 1883–1890 (2006).
   PubMed Web of Science ®Google Scholar
• Creighton CJ Chang JC Rosen JM . Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implication in breast cancer. J. Mammary Gland Biol. Neoplasia.15 (2), 253–260 (2010).
   PubMed Web of Science ®Google Scholar
• Lee CJ Dosch J Simeone DM . Pancreatic cancer stem cells. J. Clin. Oncol.26 (17), 2806–2812 (2008).
   PubMed Web of Science ®Google Scholar
• Bonnet D Dick JE . Human acute myeloid leukemia is organized as hierarchy that originates from a primitive hematopoietic cell. Nat. Med.3, 730–737 (1997).
   PubMed Web of Science ®Google Scholar
• Singh SK Clarke ID Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res.63, 5821–5828 (2003).
   PubMed Web of Science ®Google Scholar
• Singh SK Hawkins C Phylogenies TF Compare EP . Identification of human brain tumour initiating cells. Nature432, 396–401 (2004).
   PubMed Web of Science ®Google Scholar
• Mao XG Zhang X Xue XY et al. Brain tumor stem-like cells identified by neural stem cell marker CD15. Transl. Oncol.2, 247–257 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Hajj M Wicha MS Benito-Hernandez A Morrison SJ Clarke MF . Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA100, 3983–3988 (2003).
   PubMed Web of Science ®Google Scholar
• Ginestier C Hur MH Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell1 (5), 555–567 (2007).
   PubMed Web of Science ®Google Scholar
• O'Brien CA Pollett A Gallinger S Dick JE . A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature445, 106–110 (2007).
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L Lombardi DG Pilozzi E et al. Identification and expansion of human colon-cancer initiating cells. Nature445, 111–115 (2007).
   PubMed Web of Science ®Google Scholar
• Dalerba P Dylla SJ Park IK et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl Acad. Sci. USA104, 10158–10163 (2007).
   PubMed Web of Science ®Google Scholar
• Meng E Long B Sullivan P et al. CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin. Exp. Metastasis29, 939–948 (2012).
   PubMed Web of Science ®Google Scholar
• Ferrandina G Bonanno G Pierelli L et al. Expression of CD133–1 and CD133–2 in ovarian cancer. Int. J. Gynecol. Cancer18, 506–514 (2008).
   PubMed Web of Science ®Google Scholar
• Luo L Zeng J Liang B et al. Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. Exp. Mol. Pathol.91, 596–602 (2011).
   PubMed Web of Science ®Google Scholar
• Collins AT Berry PA Hyde C et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res.65, 10946–10951 (2005).
   PubMed Web of Science ®Google Scholar
• Kim CFB Jackson EL Woolfenden AE et al. Identification of bronchioalveolar stem cells normal lung and lung cancer. Cell121, 823–835 (2005).
   PubMed Web of Science ®Google Scholar
• Eramo A Lotti F Sette G et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ.15, 504–514 (2008).
   PubMed Web of Science ®Google Scholar
• Takaishi S Okumura T Tu S et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells27, 1006–1020 (2009).
   PubMed Web of Science ®Google Scholar
• Yamashita T Honda M Nio K et al. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Cancer Res.70, 4687–4697 (2010).
   PubMedGoogle Scholar
• Hermann PC Huber SL Herrler T et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell1, 313–323 (2007).
   PubMed Web of Science ®Google Scholar
• Clarke MF Dick JE Dirks PB et al. Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res.66, 9339–9344 (2006).
   PubMedGoogle Scholar
• Bauerschmitz GJ Ranki T Kangasniemi L et al. Tissue-specific promoter active in CD44+CD24-/low breast cancer cells. Cancer Res.68 (14), 5533–5539 (2008).
   PubMed Web of Science ®Google Scholar
• Lee CJ Dosch J Simeone DM . Pancreatic cancer stem cells. J. Clin. Oncol.26, 2806–2812 (2008).
   PubMed Web of Science ®Google Scholar
• Chen KL Pan F Jiang H et al. Highly enriched CD133(+) CD44(+) stem-like cells with CD133(+) CD44(high) metastatic subset in _hCT116 colon cancer cells. Clin. Exp. Metastasis28 (8), 751–763 (2011).
   PubMed Web of Science ®Google Scholar
• Lapidot T Sirard C Vormoor J et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature367, 645–648 (1994).
   PubMed Web of Science ®Google Scholar
• Colmont CS Harding KG Piguet V Patel GK . Human skin cancer stem cells: a tale of mice and men. Exp. Dermatol.21, 576–580 (2012).
   PubMedGoogle Scholar
• Kreso A Dick JE . Evolution of the cancer stem cell model. Cell Stem Cell14 (3), 275–291 (2014).
   PubMed Web of Science ®Google Scholar
• Chen T Dent SYR . Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat. Rev. Genet.15 (2), 93–106 (2014).
   PubMed Web of Science ®Google Scholar
• Sun L Mathews LA Cabarcas SM et al. Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells31 (8), 1454–1466 (2013).
   PubMed Web of Science ®Google Scholar
• Suvà ML Riggi N Bernstein BE . Epigenetic reprogramming in cancer. Science339 (6127), 1567–1570 (2013).
   PubMed Web of Science ®Google Scholar
• Wend P Fang L Zhu Q et al. Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J.32 (14), 1977–1989 (2013).
   PubMed Web of Science ®Google Scholar
• Jamieson CH Ailles LE Dylla SJ et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med.351, 657–667 (2004).
   PubMed Web of Science ®Google Scholar
• Korkaya H Paulson A Charafe-Jauffret E et al. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol.7 (6), e1000121 (2009).
   PubMed Web of Science ®Google Scholar
• Hoey T Yen WC Axelrod F et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell5, 168–177 (2009).
   PubMed Web of Science ®Google Scholar
• Taketo MM . Reflections on the spread of metastasis to cancer prevention. Cancer Prev. Res.4, 324–328 (2011).
   PubMed Web of Science ®Google Scholar
• Liu S Dontu G Mantle ID et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res.66 (12), 6063–6071 (2006).
   PubMed Web of Science ®Google Scholar
• Varnat F Duquet A Malerba M et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signaling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol. Med.1, 338–351 (2009).
   PubMed Web of Science ®Google Scholar
• Takezaki T Hide T Takanaga H Nakamura H Kuratsu J Kondo T . Essential role of the Hedgehog signaling pathway in human glioma-initiating cells. Cancer Sci.102, 1306–1312 (2011).
   PubMed Web of Science ®Google Scholar
• Nimmo RA Slack FJ . An elegant mirror: microRNAs in stem cells, developmental timing and cancer. Chromosoma118 (4), 405–418 (2009).
   PubMed Web of Science ®Google Scholar
• Liu B Sun L Song E . Non-coding RNAs regulate tumor cell plasticity. Sci. China Life Sci.56 (10), 886–890 (2013).
   PubMed Web of Science ®Google Scholar
• Bartel DP . MicroRNAs: Genomics biogenesis, mechanism, and function. Cell116, 281–297 (2004).
   PubMed Web of Science ®Google Scholar
• Stefani G Slack FJ . Small noncoding RNAs in animal development. Nat. Rev. Mol. Cell Biol.9, 219–230 (2008).
   PubMed Web of Science ®Google Scholar
• Denli AM Tops BBJ Plasterk RHA Ketting REF Hannon GJ . Processing of primary microRNAs by the Microprocessor complex. Nature432, 231–235 (2004).
   PubMed Web of Science ®Google Scholar
• Gregory RI Yan KP Amuthan G et al. The Microprocessor complex mediates the genesis of microRNAs. Nature432, 235–240 (2004).
   PubMed Web of Science ®Google Scholar
• Hutvágner G Zamore PD . A microRNA in a multiple-turnover RNAi enzyme complex. Science297, 2056–2030 (2002).
   PubMed Web of Science ®Google Scholar
• Hammond SM . Dicing and slicing: The core machinery of the RNA interference pathway. FEBS Lett.579 (26), 5822–5829 (2005).
   PubMed Web of Science ®Google Scholar
• Gregory RI Chendrimada TP Cooch N Shiekhattar R . Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell123, 631–640 (2005).
   PubMed Web of Science ®Google Scholar
• Eini R Dorssers LCJ Looijenga LHJ . Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. Int. J. Dev. Biol.57, 319–332 (2013).
   PubMed Web of Science ®Google Scholar
• Lee RC Feinbaum RL Ambros V . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell75, 843–854 (1993).
   PubMed Web of Science ®Google Scholar
• Lau NC Lim LP Weinstein EG Bartel DP . An abundant class of tiny RNAs with probable regulatory roles in C. elegans. Science294, 858–862 (2001).
   PubMed Web of Science ®Google Scholar
• miRBase: the miRNA database . www.mirbase.org.
   Google Scholar
• Bentwich I Avniel A Karov Y et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet.37, 766–770 (2005).
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M Rauhut R Meyer J et al. New microRNAs from mouse and human. RNA9, 175–179 (2003).
   PubMed Web of Science ®Google Scholar
• Bernstein E Kim SY Carmell MA et al. Dicer is essential for mouse development. Nat. Genet.35, 215–217 (2003).
   PubMed Web of Science ®Google Scholar
• Kanellopoulou C Muljo SA Kung AL et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev.19, 489–501 (2005).
   PubMed Web of Science ®Google Scholar
• Wang Y Medvid R Melton C Jaenisch R Blelloch R . DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet.39, 380–385 (2007).
   PubMed Web of Science ®Google Scholar
• Choi YJ Lin CP Ho JJ et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol.13, 1353–1360 (2011).
   PubMed Web of Science ®Google Scholar
• Yu J Vodyanik MA Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science318, 1917–1920 (2007).
   PubMed Web of Science ®Google Scholar
• Guessous F Zhang Y Kofman A et al. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle9, 1031–1036 (2010).
   PubMed Web of Science ®Google Scholar
• Godlewski J Nowicki MO Bronisz A et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell37, 620–632 (2010).
   PubMed Web of Science ®Google Scholar
• Silber J Lim DA Petritsch C et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med.6, 14 (2008).
   PubMed Web of Science ®Google Scholar
• Godlewski J Nowicki MO Bronisz A et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res.68, 9125–9130 (2008).
   PubMed Web of Science ®Google Scholar
• Garzia L Andolfo I Cusanelli E et al. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE4, e4998 (2009).
   PubMed Web of Science ®Google Scholar
• Gal H Pandi G Kanner AA et al. MIR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem. Biophys. Res. Commun.376, 86–90 (2008).
   PubMed Web of Science ®Google Scholar
• Johansson J Berg T Kurzejamska E et al. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene32 (50), 5614–5624 (2013).
   PubMed Web of Science ®Google Scholar
• Huang S Chen L . miR-888 regulates side population properties and cancer metastasis in breast cancer cells. Biochem. Biophys. Res. Commun.450, 1234–1240 (2014).
   PubMed Web of Science ®Google Scholar
• Yu F Yao H Zhu P et al. Let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell131, 1109–1123 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang H Cai K Wang J et al. MiR-7, inhibited indirectly by LincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells32 (11), 2858–2868 (2014).
   PubMed Web of Science ®Google Scholar
• Shimono Y Zabala M Cho RW et al. Downregulation of miR-200c links breast cancer stem cells with normal stem cells. Cell138, 592–603 (2009).
   PubMed Web of Science ®Google Scholar
• Yu Y Kanwar SS Patel BB et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis33, 68–76 (2012).
   PubMed Web of Science ®Google Scholar
• Song B Wang Y Xi Y et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene28, 4065–4074 (2009).
   PubMed Web of Science ®Google Scholar
• Nicolas FE Pais H Schwach F et al. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA14, 2513–2520 (2008).
   PubMed Web of Science ®Google Scholar
• Song B Wang Y Titmus MA et al. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Mol. Cancer9, 96 (2010).
   PubMed Web of Science ®Google Scholar
• Bu P Chen KY Chen JH et al. A microRNA-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell12, 602–615 (2013).
   PubMed Web of Science ®Google Scholar
• Yu XF Zou J Bao ZJ Dong J . miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J. Gastroenterol.17, 4711–4717 (2011).
   PubMed Web of Science ®Google Scholar
• Xu XT Xu Q Tong JL et al. MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer. Br. J. Cancer106, 1320–1330 (2012).
   PubMed Web of Science ®Google Scholar
• Bitarte N Bandres E Boni V et al. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells29, 1661–1671 (2011).
   PubMed Web of Science ®Google Scholar
• Xu CX Xu M Tan L et al. microRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J. Biol. Chem.287 (42), 34970–34978 (2012).
   PubMed Web of Science ®Google Scholar
• Cheng W Liu T Wan X Gao Y Wang H . MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J.279, 2047–2059 (2012).
   PubMed Web of Science ®Google Scholar
• Wang Z Ting Z Li Y Chen G Lu Y Hao X . microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin. Oncol. Lett.6 (3), 789–794 (2013).
   PubMed Web of Science ®Google Scholar
• Wu Q Guo R Lin M Zhou B Wang Y . microRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Gynecol. Oncol.122 (1), 149–154 (2011).
   PubMed Web of Science ®Google Scholar
• Liu C Kelnar K Liu B et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med.17, 211–215 (2011).
   PubMed Web of Science ®Google Scholar
• Kashat M Azzouz L Sarkar SH Kong D Li Y Sarkar FH . Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. Am. J. Transl. Res.4, 432–442 (2012).
   PubMed Web of Science ®Google Scholar
• Li K Liu C Zhou B et al. Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells. Int. J. Mol. Sci.14 (6), 11981–11993 (2013).
   PubMed Web of Science ®Google Scholar
• Jin M Zhang T Liu C et al. miRNA-128 Suppresses Prostate Cancer by Inhibiting BMI-1 to Inhibit Tumor-Initiating Cells. Cancer Res.74 (15), 4183–4195 (2014).
   PubMed Web of Science ®Google Scholar
• Hsieh IS Chang KC Tsai YT et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis34 (3), 530–538 (2013).
   PubMed Web of Science ®Google Scholar
• Stupp R Gander M Leyvraz S Newlands E . Current and future developments in the use of temozolomide for the treatment of brain tumours. Lancet Oncol.2, 552–560 (2001).
   PubMed Web of Science ®Google Scholar
• Ostrom QT Gittleman H Farah P et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro. Oncol.15, ii1–ii56 (2013).
   PubMed Web of Science ®Google Scholar
• Ricard D Idbaih A Ducray F Lahutte M Hoang-Xuan K Delattre JY . Primary brain tumours in adults. Lancet379, 1984–1996 (2012).
   PubMed Web of Science ®Google Scholar
• Miraglia S Godfrey W Yin A et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood90, 5013–5021 (1997).
   PubMed Web of Science ®Google Scholar
• Yin AH Miraglia S Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood90, 5002–5012 (1997).
   PubMed Web of Science ®Google Scholar
• Yu L Baxter PA Voicu H et al. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro. Oncol.12, 580–594 (2010).
   PubMed Web of Science ®Google Scholar
• Li Y Guessous F Zhang Y et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res.69, 7569–7576 (2009).
   PubMed Web of Science ®Google Scholar
• Li KKW Pang JC Ching AK et al. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum. Pathol.40, 1234–1243 (2009).
   PubMed Web of Science ®Google Scholar
• Xia H Cheung WKC Ng SS et al. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J. Biol. Chem.287, 9962–9971 (2012).
   PubMed Web of Science ®Google Scholar
• Ginestier C Hur MH Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell1, 555–567 (2007).
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ . Cancer stem cells and novel targets for antitumor strategies. Curr. Pharm. Des.18, 2838–2849 (2012).
   PubMed Web of Science ®Google Scholar
• Okuda H Xing F Pandey PR et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res.73, 1434–1444 (2013).
   PubMed Web of Science ®Google Scholar
• Gregory PA Bert AG Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol.10, 593–601 (2008).
   PubMed Web of Science ®Google Scholar
• Park SM Gaur AB Lengyel E Peter ME . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev.22, 894–907 (2008).
   PubMed Web of Science ®Google Scholar
• Kong W Yang H He L et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol.28 (22), 6773–6784 (2008).
   PubMed Web of Science ®Google Scholar
• Ma L Young J Prabhala H et al. miR-9, aMYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol.12 (3), 247–256 (2010).
   PubMed Web of Science ®Google Scholar
• Gwak JM Kim HJ Kim EJ et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res. Treat.147 (1), 39–49 (2014).
   PubMed Web of Science ®Google Scholar
• Huang EH Hynes MJ Zhang T et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res.69, 3382–3389 (2009).
   PubMed Web of Science ®Google Scholar
• Lengyel E . Ovarian cancer development and metastasis. Am. J. Pathol.177, 1053–1064 (2010).
   PubMed Web of Science ®Google Scholar
• Klonisch T Wiechec E Hombach-Klonisch S et al. Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol. Med.14 (10), 450–460 (2008).
   PubMed Web of Science ®Google Scholar
• Gottesman MM Fojo T Bates SE . Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer2, 48–58 (2002).
   PubMed Web of Science ®Google Scholar
• Golebiewska A Brons NHC Bjerkvig R Niclou SP . Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell8 (2), 136–147 (2011).
   PubMed Web of Science ®Google Scholar
• Xu XT Xu Q Tong JL et al. MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer. Br. J. Cancer106 (7), 1320–1330 (2012).
   PubMed Web of Science ®Google Scholar
• Bitarte N Bandres E Boni V et al. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells29, 1661–1671 (2011).
   PubMed Web of Science ®Google Scholar
• Aziz MH Kumar R Ahmad N . Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanism. Int. J. Oncol.23, 17–28 (2003).
   PubMed Web of Science ®Google Scholar
• Hagiwara K Kosaka N Yoshioka Y Takahashi RU Takeshita F Ochiya T . Stilbene derivatives promote Ago-2-dependent tumour-suppressive microRNA activity. Sci. Rep.2, 314 (2012).
   PubMed Web of Science ®Google Scholar
• Yang F Nam S Brown CE et al. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS ONE9 (4), e94443 (2014).
   PubMed Web of Science ®Google Scholar
• Bao B Ali S Ahmad A et al. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. PLoS ONE7 (12), e50165 (2012).
   PubMed Web of Science ®Google Scholar
• Ono M Kosaka N Tominaga N et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci. Signal.7 (332), ra63 (2014).
   PubMed Web of Science ®Google Scholar
• Rombouts K Carloni V Mello T et al. Myristoylated alanine-rich protein kinase C substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. Cancer Lett.333, 244–252 (2013).
   PubMed Web of Science ®Google Scholar
• Zhu S Pan W Song X et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-a. Nat. Med.18, 1077–1086 (2012).
   PubMed Web of Science ®Google Scholar
• Pihlmann M Askou AL Aagaard L et al. Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo. J. Gene Med.14, 328–338 (2012).
   PubMed Web of Science ®Google Scholar
• Kasinski AL Slack FJ . miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res.72, 5576–5587 (2012).
   PubMed Web of Science ®Google Scholar
• Pfeifer A Verma IM . Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet.2, 177–211 (2001).
   PubMed Web of Science ®Google Scholar
• Thomas CE Ehrhardt A Kay MA . Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet.4, 346–358 (2003).
   PubMed Web of Science ®Google Scholar
• Tomanin R Scarpa M . Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. Curr. Gene Ther.4, 357–372 (2004).
   PubMed Web of Science ®Google Scholar
• Markman JL Rekechenetskiy A Holler E Ljubimova JY . Nanomedicine therapeutic approaches to overcome cancer. Adv. Drug Deliv. Rev.65, 1866–1879 (2013).
   PubMed Web of Science ®Google Scholar
• S⊘rensen DR Leirdal M Sioud M . Gene silencing by systemic delivery of synthetic sirnas in adult mice. J. Mol. Biol.327, 761–766 (2003).
   PubMed Web of Science ®Google Scholar
• Verma UN Surabhi RM Schmaltieg A Schmaltieg A Becerra C Gaynor RB . Small interfering RNAs directed against b-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res.9, 1291–1300 (2003).
   PubMed Web of Science ®Google Scholar
• Yano J Hirabayashi K Nakagawa S-I et al. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin. Cancer Res.10, 7721–7726 (2004).
   PubMed Web of Science ®Google Scholar
• Urban-Klein B Werth S Abuharbeid S Czubayko F Aigner A . RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther.12, 461–466 (2005).
   PubMed Web of Science ®Google Scholar
• Xu D Takeshita F Hino Y et al. miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol.193 (2), 409–424 (2011).
   PubMed Web of Science ®Google Scholar
• Civenni G Malek A Albino D et al. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer. Cancer Res.73 (22), 6816–6827 (2013).
   PubMed Web of Science ®Google Scholar
• Tazawa H Tsuchiya N Izumiya M Nakagama H . Growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA104, 2–7 (2007).
   Web of Science ®Google Scholar
• Minakuchi Y Takeshita F Kosaka N et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res.32, e109 (2004).
   PubMed Web of Science ®Google Scholar
• Takeshita F Minakuchi Y Nagahara S et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl Acad. Sci. USA102, 12177–12182 (2005).
   PubMed Web of Science ®Google Scholar
• Takeshita F Patrawala L Osaki M et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther.18, 181–187 (2010).
   PubMed Web of Science ®Google Scholar
• Osaki M Takeshita F Sugimoto Y et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol. Ther.19 (6), 1123–1130 (2011).
   PubMed Web of Science ®Google Scholar
• Al-jamal KT Gherardini L Bardi G Nunes A Guo C Bussy C . Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc. Natl Acad. Sci. USA108, 10952–10957 (2011).
   PubMed Web of Science ®Google Scholar
• Kosaka N Iguchi H Ochiya T . Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci.101 (10), 2087–2092 (2010).
   PubMed Web of Science ®Google Scholar
• Weber JA Baxter DH Zhang S et al. The microRNA spectrum in 12 body fluids. Clin. Chem.56 (11), 1733–1741 (2010).
   PubMed Web of Science ®Google Scholar
• Kosaka N Izumi H Sekine K Ochiya T . microRNA as a new immune-regulatory agent in breast milk. Silence1 (1), 7 (2010).
   PubMedGoogle Scholar
• Mitchell PS Parkin RK Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA105 (30), 10513–10518 (2008).
   PubMed Web of Science ®Google Scholar
• Park NJ Zhou H Elashoff D et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res.15 (17), 5473–5477 (2009).
   PubMed Web of Science ®Google Scholar
• Valadi H Ekstrom K Bossios A Sjostrand M Lee JJ Lotvall JO . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol.9 (6), 654–659 (2007).
   PubMed Web of Science ®Google Scholar
• Zitvogel L Regnault A Lozier A et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat. Med.4 (5), 594–600 (1998).
   PubMed Web of Science ®Google Scholar
• Van Niel G Raposo G Candalh C et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology121 (2), 337–349 (2001).
   PubMed Web of Science ®Google Scholar
• Wolfers J Lozier A Raposo G et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med.7 (3), 297–303 (2001).
   PubMed Web of Science ®Google Scholar
• Pegtel DM Cosmopoulos K Thorley-Lawson DA van Eijndhoven MA Hopmans ES Lindenberg JL . Functional delivery of viral miRNAs via exosomes. Proc. Natl Acad. Sci. USA107 (14), 6328–6333 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang Y Liu D Chen X Li J Li L Bian Z . Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell39 (1), 133–144 (2010).
   PubMed Web of Science ®Google Scholar
• Kosaka N Iguchi H Yoshioka Y Takeshita F Matsuki Y Ochiya T . Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem.285 (23), 17442–17452 (2010).
   PubMed Web of Science ®Google Scholar
• Kosaka N Iguchi H Yoshioka Y Hagiwara K Takeshita F Ochiya T . Competitive interactions of cancer cells and normal cells via secretory microRNAs. J. Biol. Chem.287 (2), 1397–1405 (2012).
   PubMed Web of Science ®Google Scholar
• Ohno S Takanashi M Sudo K Ueda S Ishikawa A Matsuyama N . Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther.21 (1), 185–191 (2013).
   PubMed Web of Science ®Google Scholar